Fig. 2From: Unlocking the potential of sacubitril/valsartan therapy in improving ECG and echocardiographic parameters in heart failure patients with reduced ejection fraction (HErEF)Pearson correlation coefficient (r) and p-value (p) between corrected QT interval change and LV ejection fraction after S/V therapy in HErEF patientsBack to article page